US wants ingredient in swine flu vaccine by May

Apr 28, 2009 By LAURAN NEERGAARD , AP Medical Writer

(AP) -- U.S. scientists hope to have a key ingredient for a swine flu vaccine ready in early May, but tell The Associated Press that the novel virus grows slowly in eggs - the chief way flu vaccines are made.

Even if all goes well, it still will take months before any shots are available for the necessary safety testing in volunteers.

Dr. Jesse Goodman, the Food and Drug Administration's swine flu chief, said Tuesday that scientists are working, in his words, "at 100 miles an hour" to create good raw material to deliver to manufacturers.

The researchers must engineer a strain that could trigger the without causing illness. At the Centers for Disease Control and Prevention, chief Dr. Ruben Donis says that work is about a third completed.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Medical charity accuses US of pushing India to ease patent rules

add to favorites email to friend print save as pdf

Related Stories

Swine flu cases up to 7, probe expanding

Apr 23, 2009

(AP) -- Health officials say a unique type of swine flu has now been diagnosed in seven people in California and Texas, up from the two reported earlier this week. The five new cases in the two states have all recovered, ...

Mexico City closes museums to stop flu outbreak

Apr 24, 2009

(AP) -- Mexico's federal government has closed museums, libraries, and state-run theaters as well as schools in its overcrowded capital to stop a swine flu outbreak authorities say may have killed as many ...

Bird flu vaccine not effective in trial

Feb 17, 2006

A highly anticipated bird flu vaccine trial in Australia has proven protective for only a small minority of the 400 volunteers in the clinical trial.

CDC: Mild flu season apparently winding down

Apr 07, 2009

(AP) -- The flu season is winding down and turning out to be one of the mildest in years, according to data from the U.S. Centers for Disease Control and Prevention.

Recommended for you

Ebola vaccine not before late 2016: GSK researcher

Oct 17, 2014

An Ebola vaccine by British pharmaceuticals giant GlaxoSmithKline may not be ready for commercial use until late 2016 and should therefore not be seen as the "primary answer" to the current outbreak, a company researcher ...

Chimerix gets FDA OK to test drug for Ebola

Oct 17, 2014

(AP)—A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

Esbriet, ofev approved to treat deadly lung disease

Oct 16, 2014

(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).

FDA weighs removing bolded warning from Chantix

Oct 14, 2014

(AP)—The Food and Drug Administration will ask a panel of experts later this week whether a bold-letter warning on the anti-smoking drug Chantix should be removed based on company-supported evidence that the drug does not ...

Drug-coated balloon catheter approved

Oct 13, 2014

(HealthDay)—The first drug-coated balloon catheter designed to clear narrowed or blocked arteries in the thigh and knee has been approved by the U.S. Food and Drug Administration.

User comments : 0